← back to search

Piotr Jankowski

Postgraduate School of Molecular Medicine · PL
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Blood Pressure and Hypertension Studies, Lipoproteins and Cardiovascular Health, Cardiac Health and Mental Health, and Cardiovascular Health and Disease Prevention.
h-index
43
citations
42,702
works
438
NIH funding
primary concept
Medicine
email

Recent publications

Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions.
2026cited by 2position: contributordoi
Two Decades of Progress in Cardiovascular Health: Declining Mortality and Years of Life Lost from Acute Myocardial Infarction in Poland.
2026cited by 0position: contributordoi
Obesity and Beyond: Lifestyle Patterns and Cardiometabolic Burden in High-Risk Patients with Coronary Artery Disease-Moving Toward Personalized Prevention.
2026cited by 0position: contributordoi
Comprehensive assessment of gastroscopic findings and quality of life using the GERD-HRQL questionnaire following single anastomosis sleeve ileal (SASI) bypass.
2026cited by 0position: contributordoi
Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study.
2026cited by 0position: contributordoi
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease
Journal of the American College of Cardiology 2025cited by 25position: middledoi
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease
Journal of the American College of Cardiology 2025cited by 24position: contributordoi
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study
European Journal of Preventive Cardiology 2025cited by 9position: middledoi
Implementation of cardiovascular prevention guidelines in clinical practice. Results from the POLASPIRE II survey.
2025cited by 7position: contributordoi
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study.
2025cited by 5position: contributordoi
Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease - endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology.
2025cited by 4position: contributordoi
Prevalence of Nutrient Deficiencies Following Bariatric Surgery-Long-Term, Prospective Observation.
2025cited by 3position: contributordoi
Iron Deficiency Anemia Following Bariatric Surgery: A 10-Year Prospective Observational Study.
2025cited by 3position: contributordoi
Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions.
2025cited by 3position: contributordoi
Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE
Atherosclerosis 2025cited by 3position: contributordoi
Rosuvastatin-Based Combination Treatment with Acetylsalicylic Acid or Ezetimibe in the Management of Patients at High and Very High Cardiovascular Risk. Expert Opinion Paper of the Polish Lipid Association 2025.
Archives of Medical Science 2025cited by 3position: contributordoi
The Association of Lipoprotein(A) and Coronary Artery Calcium in Primary Prevention Patients-Data from the STAR-Lp(A) Study.
2025cited by 2position: contributordoi
Long-term trends in cardiovascular risk factors and cardiovascular risk following bariatric surgery: A 10-year prospective cohort study.
2025cited by 2position: contributordoi
Self-Efficacy and Acceptance of Illness Among Older Patients with Heart Failure.
2025cited by 2position: contributordoi
Guidelines for the management of hypertension in Poland 2024 - the position paper of the Polish Society of Hypertension and Polish Cardiac Society experts.
2025cited by 2position: contributordoi
Cardiac Rehabilitation in Patients with Coronary Heart Disease - Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO Regions.
2025cited by 2position: contributordoi
Is a Single Lipoprotein(a) Measurement Once in a Lifetime Sufficient? The Results from the STAR-Lp(a) Study.
2025cited by 1position: contributordoi
Cardiac symptoms in patients 3-6 months after contracting COVID-19- data from the polish STOP-COVID registry.
2025cited by 1position: contributordoi
Comparison of Inpatient and Outpatient Cardiac Rehabilitation Following Myocardial Infarction.
2025cited by 1position: contributordoi
Management and predictors of event-free survival in nonagenarians with myocardial infarction: A nationwide analysis.
2025cited by 1position: contributordoi
Risk factors for cardiovascular diseases: the focus on primary prevention.
2025cited by 1position: contributordoi
Predictors of Cardiovascular Symptoms Among Long COVID Patients: Data from the Polish Long COVID Cardiovascular (PoLoCOV-CVD) Study.
2025cited by 1position: contributordoi
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE.
2025cited by 1position: contributordoi
Lipid profile and the variables associated with control of selected lipid parameters in patients of a large multi-specialist hospital in Poland - the Jurasz Lipid Study (JLS).
2025cited by 1position: contributordoi
Sociodemographic, disease-related and lifestyle determinants of health-related quality of life among older patients hospitalized with heart failure.
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 54 papers (2020–2026)Mariusz Gąsior · Medical University of Silesia19 papers (2019–2025)Maciej Banach · University of Hong Kong17 papers (2021–2025)Jacek Kubica · University of Bydgoszcz12 papers (2022–2025)Michal Chudzik · Medical University of Lodz12 papers (2022–2025)Joanna Kapusta · Medical University of Lodz11 papers (2022–2025)Dirk De Bacquer · Ghent University10 papers (2020–2026)Agata Magdalena Bielecka-Dabrowa · Gdańsk Medical University9 papers (2022–2025)Mateusz Babicki · Wrocław University of Environmental and Life Sciences9 papers (2022–2025) · 8 papers (2021–2026)Kausik K Ray · Icahn School of Medicine at Mount Sinai8 papers (2022–2026) · 6 papers (2023–2025)Damian Kołat · University of Łódź6 papers (2022–2025)Żaneta Kałuzińska-Kołat · University of Łódź6 papers (2022–2025)Ewelina A. Dziedzic · Postgraduate School of Molecular Medicine6 papers (2021–2022)Zbigniew Kalarus · German Centre for Cardiovascular Research6 papers (2020–2025)Jarosław D. Kasprzak · Mossakowski Medical Research Institute, Polish Academy of Sciences5 papers (2020–2025)Agnieszka Mastalerz-Migas · Wrocław University of Environmental and Life Sciences5 papers (2022–2024)Monika Burzyńska · Medical University of Lodz5 papers (2025–2026)Jarosław Pinkas · Postgraduate School of Molecular Medicine5 papers (2021–2025)